<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Here we show that patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) have a severe deficiency of <z:chebi fb="0" ids="33563">glycolipid</z:chebi> reactive Valpha24+/Vbeta11+ natural killer T (NKT) cells, but not NK cells or CD4+ or CD8+ T cells </plain></SENT>
<SENT sid="1" pm="."><plain>Neither the blood nor marrow of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients had detectable interferon-gamma-producing NKT cells in response to the NKT ligand, alpha-galactosyl <z:chebi fb="7" ids="17761">ceramide</z:chebi>, although <z:e sem="disease" ids="C0021400" disease_type="Disease or Syndrome" abbrv="FLU">influenza</z:e>-virus-specific effector T-cell function was preserved </plain></SENT>
<SENT sid="2" pm="."><plain>This severe and selective deficiency of an important immune regulatory cell may contribute to the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>